EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSELUG00000006310
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSELUG00000014659
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSELUG00000018673
Gene Symbol: SSTR5
3 Cross references
187 Possible Orthologues:

Somatostatin Receptor Type 5

Ensembl ID : ENSELUG00000000893
Gene Symbol: LOC105031196
2 Cross references
184 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSELUG00000014531
Gene Symbol: LOC105018992
2 Cross references
202 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSELUG00000003535
Gene Symbol: S1PR1
3 Cross references
193 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSELUG00000016990
Gene Symbol: SYK
3 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSELUG00000014836
Gene Symbol: LOC105008018
3 Cross references
209 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSELUG00000017525
Gene Symbol: SRD5A2B
1 Cross references
192 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSELUG00000008616
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Substance-P Receptor

Ensembl ID : ENSELUG00000004438
Gene Symbol: LOC105015231
3 Cross references
194 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSELUG00000008015
Gene Symbol: SNCA
4 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).